Zhongnan Hospital

This study tests a combination of two drugs, Utidelone and Toripalimab, in 32 people with recurrent or metastatic cervical cancer that has worsened after standard chemotherapy. The goal is to see if the treatment can shrink or eliminate tumors and to check for side effects. All p…

This study tests a chemotherapy regimen called FULIRI combined with targeted therapy (bevacizumab or cetuximab) as a first treatment for people with colorectal cancer that has spread to the liver. The goal is to shrink the liver tumors enough so they can be surgically removed or …

This study tests a new radioactive imaging agent called 68Ga-B6FA-01, designed to make PET/CT scans more accurate for detecting and staging solid tumors. The probe targets two different markers found on cancer cells and their surroundings, which may improve image clarity. About 1…

This study tests a new imaging agent called 68Ga-SFB6-ZN01 that attaches to a protein found on many cancer cells. About 98 adults with known or suspected cancer will receive one injection and have a PET/CT scan. The goal is to see if the agent is safe and can accurately detect tu…